Vimta Labs Limited (BOM:524394)

Market Cap	24.79B
Revenue (ttm)	3.85B
Net Income (ttm)	780.40M
Shares Out	44.64M
EPS (ttm)	17.34
PE Ratio	33.49
Forward PE	n/a
Dividend	1.00 (0.18%)
Ex-Dividend Date	May 30, 2025

Volume	14,460
Average Volume	6,234
Open	598.15
Previous Close	579.20
Day's Range	551.55 - 598.15
52-Week Range	372.50 - 902.85
Beta	-0.35
RSI	33.55
Earnings Date	Feb 14, 2026

About Vimta Labs

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufactu...

• Industry: Commercial Physical and Biological Research
• Founded: 1984
• Employees: 1,315
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524394

Financial Performance

In 2024, Vimta Labs's revenue was 3.45 billion, an increase of 19.25% compared to the previous year's 2.90 billion. Earnings were 667.55 million, an increase of 36.76%.